TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 28 filers reported holding TSCAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $106,752 | +10.9% | 41,700 | +8.3% | 0.00% | – |
Q2 2023 | $96,250 | +91.0% | 38,500 | +60.4% | 0.00% | – |
Q1 2023 | $50,400 | +15.4% | 24,000 | -10.4% | 0.00% | – |
Q4 2022 | $43,684 | +6.5% | 26,800 | +100.0% | 0.00% | – |
Q3 2022 | $41,000 | -2.4% | 13,400 | 0.0% | 0.00% | – |
Q2 2022 | $42,000 | +20.0% | 13,400 | +6.3% | 0.00% | – |
Q1 2022 | $35,000 | -36.4% | 12,600 | +3.3% | 0.00% | – |
Q4 2021 | $55,000 | -46.1% | 12,200 | 0.0% | 0.00% | – |
Q3 2021 | $102,000 | – | 12,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 630,000 | $1,323,000 | 30.82% |
Deer Management Co. LLC | 1,245,505 | $2,615,561 | 0.24% |
Simplify Asset Management Inc. | 546,916 | $1,148,524 | 0.16% |
Alphabet Inc. | 1,077,080 | $2,261,868 | 0.12% |
Newtyn Management, LLC | 236,800 | $497,280 | 0.10% |
DC Investments Management, LLC | 35,563 | $74,682 | 0.09% |
Privium Fund Management (UK) Ltd | 15,825 | $40,987 | 0.03% |
Baker Brothers Advisors | 2,784,792 | $5,848,063 | 0.03% |
Tekla Capital Management LLC | 200,000 | $420,000 | 0.02% |
NewEdge Wealth, LLC | 91,463 | $192,072 | 0.01% |